TAK - TAKEDA PHARMACEUTICAL CO LTD
17.88
0.120 0.671%
Share volume: 2,310,139
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$17.76
0.12
0.01%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2023 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | |
| Report Date | 07-27-2023 | 10-30-2023 | |
| Assets | |||
| Total Assets | 102.226 B | 99.561 B | |
| Current Assets | 17.083 B | 16.482 B | |
| Inventories | 7.487 B | 7.738 B | |
| Other Current Assets | 1.604 B | 1.299 B | |
| Short Term Investments | 1.604 B | 1.299 B | |
| Total Receivables | 5.705 B | 5.276 B | |
| Current Cash | 2.186 B | 2.129 B | |
| Total Non-current Assets | 85.143 B | 83.078 B | |
| Property Plant Equipment | 12.407 B | 12.680 B | |
| Other Assets | 2.441 B | 2.497 B | |
| Intangible Assets | 31.195 B | 29.472 B | |
| Goodwill | 35.811 B | 35.488 B | |
| Liabilities and shareholders’ equity | |||
| Total Liabilities and shareholders’ equity | 102.226 B | 99.561 B | |
| Total liabilities | 54.398 B | 52.228 B | |
| Total current liabilities | 17.288 B | 15.850 B | |
| Accounts Payable | 3.047 B | 2.819 B | |
| Other liabilities | 1.894 B | 1.508 B | |
| Current long term debt | 5.050 B | 3.899 B | |
| Long term debt | 33.349 B | 33.334 B | |
| Other liabilities | 1.894 B | 1.508 B | |
| Minority interest | 4.264 M | 4.505 M | |
| Total Shareholder equity | 47.828 B | 47.333 B | |
| Common stock | 3.109 B | 3.131 B | |
| Retained earnings | 10.297 B | 9.680 B |